Form 4: Exelixis EVP & General Counsel Reports Stock Transaction
SEC Form 4 Filing
Exelixis' EVP & General Counsel, Jeffrey Hessekiel, reports the withholding of 14,672 shares for tax obligations and holdings of 515,653 shares, including those from restricted stock units and a 401(k) plan.
Summary
- Jeffrey Hessekiel, EVP & General Counsel at Exelixis, Inc., filed a Form 4 detailing changes in his beneficial ownership of company stock.
- On November 15, 2024, 14,672 shares of common stock were withheld to cover tax obligations related to vesting performance-based restricted stock units.
- These restricted stock units were awarded on September 11, 2020, and the performance criteria were certified on September 6, 2023.
- Following the transaction, Hessekiel directly owns 515,653 shares, which includes 207,072 shares from unvested restricted stock units.
- He also indirectly owns 999 shares through the Exelixis, Inc. 401(k) plan.
Sentiment
Score: 7
Explanation: The document is a routine SEC filing related to stock transactions by an executive. It is neutral in nature and expected as part of standard corporate governance.
Industry Context
This is a routine filing related to executive compensation and is typical for publicly traded companies. It provides transparency into the stock ownership of key personnel.
Comparison to Industry Standards
- Form 4 filings are standard practice for publicly traded companies in the US, as mandated by the SEC.
- The transaction is typical for executives receiving stock-based compensation, where shares are often withheld to cover tax obligations.
- The reporting of both direct and indirect holdings, including those in 401(k) plans, is consistent with SEC requirements.
- Companies like Gilead Sciences, Amgen, and Biogen also have similar filings from their executives.
Stakeholder Impact
- The transaction has a minor impact on shareholders as it reflects a routine adjustment in executive stock ownership.
- The withholding of shares for tax purposes is a standard practice and does not indicate any change in the company's financial health or outlook.
Key Dates
| Date | Description |
|---|---|
| 2020-09-11 | Date of award of performance-based restricted stock units. |
| 2023-09-06 | Date the Compensation Committee certified that Exelixis, Inc. had achieved certain performance criteria. |
| 2024-11-14 | Date of the 401(k) plan statement. |
| 2024-11-15 | Date of the stock transaction where shares were withheld for tax obligations. |
| 2024-11-19 | Date the Form 4 was signed. |
Keywords
Exelixis, stock transaction, Form 4, beneficial ownership, restricted stock units, tax withholding, 401(k), insider trading
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.